Authors
Loading...
Experimental study shows sorafenib reduces GFAP levels in retinal tissue of diabetic rats, suggesting therapeutic potential.
K.O. Usenko (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: